Zydus Lifesciences Launches Rexigo™, the Oral Once-a-Day Pill for Advanced Prostate Cancer Patients in India
Business Wire India Rexigo™ (Relugolix) is a critical therapy as it suppresses testosterone in patients with advanced prostate cancer. Rexigo™ is the first generic, oral, once-a-day pill, making it much…